44.7 percent of angiotensin receptor blocker initiators were continuously persistent to original drug class at three years.

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...

Small differences in effect on blood pressure were seen with different drug classes, which did not appear to correlate with the differences in the hard outcomes. This review suggests that first-line ...

Combining a calcium-channel blocker (CCB) with hydrochlorothiazide (HCTZ) and moderate salt intake may be best for reducing blood pressure in patients with salt-sensitive hypertension (SSH), according ...

Potent new statistics on the true burden of hypertension in the world today -- to be remembered and cited by all those concerned with the dimensions of this healthcare challenge -- were highlighted at ...

Treating blood pressure with antihypertensives like blood vessel relaxers (ARB drugs) can provide increased life expectancy ...

Objective: To compare rates of discontinuation of prescription therapy for hypertension in Medicaid patients with and without medication access restrictions. Study Design: Retrospective cohort study.

Group 1 pulmonary hypertension (or pulmonary arterial hypertension) is a rare, highly complex, and progressive disorder that is incurable and ultimately can lead to premature death. PAH causes ...

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ...